Ceftriaxone Sodium
Ceftriaxone for Injection, USP
Approved
Approval ID
19141ccd-e66c-49a2-a794-0616028495a7
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 10, 2024
Manufacturers
FDA
Hospira, Inc
DUNS: 141588017
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Ceftriaxone Sodium
PRODUCT DETAILS
NDC Product Code0409-7337
Application NumberANDA065169
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJuly 20, 2020
Generic NameCeftriaxone Sodium
INGREDIENTS (1)
CEFTRIAXONE SODIUMActive
Quantity: 250 mg in 1 1
Code: 023Z5BR09K
Classification: ACTIM
Ceftriaxone Sodium
PRODUCT DETAILS
NDC Product Code0409-7338
Application NumberANDA065169
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJuly 20, 2020
Generic NameCeftriaxone Sodium
INGREDIENTS (1)
CEFTRIAXONE SODIUMActive
Quantity: 500 mg in 1 1
Code: 023Z5BR09K
Classification: ACTIM
Ceftriaxone Sodium
PRODUCT DETAILS
NDC Product Code0409-7332
Application NumberANDA065169
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJuly 20, 2020
Generic NameCeftriaxone Sodium
INGREDIENTS (1)
CEFTRIAXONE SODIUMActive
Quantity: 1 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM
Ceftriaxone Sodium
PRODUCT DETAILS
NDC Product Code0409-7335
Application NumberANDA065169
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJuly 20, 2020
Generic NameCeftriaxone Sodium
INGREDIENTS (1)
CEFTRIAXONE SODIUMActive
Quantity: 2 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM